• Comprehend the complex aetiological influences (e.g. genetics, family environment, brain development) on the pathogenesis of these disorders
• Appreciate the assessment process for anxiety disorders in this group and the variety of treatment options, encompassing psychological therapies and psychoactive medications
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Anxiety is an uncomfortable experience charac terised by emotional (e.g. unease, distress), cognitive (e.g. fears, worries, helplessness), physiological (e.g. muscle tension) and behavioural (e.g. avoidance) changes. The anxious child commonly focuses on the future, fearful of danger, either specific or undefined. Anxiety that is excessive or contextually or developmentally inappropriate, causing signi ficant distress and/or functional impairment, can be classified as an anxiety disorder. Although rarely recognised, too little anxiety might also be considered 'disordered': callous unemotional traits may be such a manifestation (Frick 1999 ).
In ICD10, anxiety disorders are classified into a cluster of related conditions: separation anxiety, generalised anxiety, social phobia, panic disorder and simple phobias (World Health Organization 1992) . Although beyond the remit of this chapter, anxiety can feature in other psychiatric conditions. In obsessive-compulsive disorder (OCD), obsessions generate anxiety which the individual then tries to neutralise through compulsions. Indeed, DSM5 defines and differentiates obsessions and compulsions through their causal relationships with anxiety (American Psychiatric Association 2013). This may be a simplification: although compulsions may initially relieve anxiety, they can aggravate it as the disorder progresses (Heyman 2006) . Swedo et al (1998) describe separation anxiety as a characteristic feature of the proposed 'paediatric autoimmune neuro psychiatric disorders associated with streptococcal infections' (PANDAS) subset of OCD, although recent research disputes this (Murphy 2012) . Anxiety also occurs in post traumatic stress disorder (PTSD), particularly when traumatic memories are triggered. Avoidance behaviour and hypervigilance are common and can be seen as an adaptive response to avoid further dangers, albeit one that is excessive, distressing and/or impairing. Anxiety in PTSD may relate to dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis.
From an evolutionary perspective, anxiety is an emotional response intrinsically shaped by natural selection: its very purpose is to ensure safety, avoid danger and keep the individual alive (at least long enough to pass on their genes). Anxiety is therefore a normal and important facet of human experience and functioning.
The various subtypes of anxiety disorder probably evolved to give a selective advantage of superior protection against particular kinds of danger (Marks 1994 ). Yet commonalities exist between these subtypes, for example in their shared behavioural responses (Table 1) . Again, this may be evolutionarily driven, reflecting a need for flexibility in dealing with uncertain or indefinable threats. Furthermore, physiological and Vallance & Fernandez behavioural responses useful against one type of danger are likely to protect against other types as well. Indeed, our huntergatherer ancestors would have faced multiple threats: predators, starvation, climate, falls and exposure.
The shifting manifestation of anxiety through different developmental stages may also have an evolutionary basis (Table 2) . Fears tend to occur at the age they become adaptive: for example, fear of animals occurs from 2 to 3 years old, when there is increased exploration, and this may have a protective value. In adolescents, developing cognitive maturity endows individuals with a growing capacity to imagine and ruminate on abstract threats. The developmental aspect of anxiety is an important consideration: what is seen as normal for a young child may be considered a disorder in an older child. So, for example, screaming when separated from a mother may be quite normative in a preschool child, but in an 11yearold it would be unusual.
Epidemiology
Anxiety disorders are some of the most prevalent psychiatric disorders in children and adolescents, particularly among girls (Table 3) . They also frequently cooccur: at least onethird of children presenting with an anxiety disorder meet the criteria for two or more subtypes. Moreover, general comorbidity with other psychiatric disorders -including oppositional defiant disorder and attentiondeficit hyperactivity disorder (ADHD), substance misuse and depression -is approximately 40%; comorbidity with depressive disorder is about 28%. Anxiety disorders are frequently found in autism spectrum disorders, with rates as high as 84% (Muris 1998) .
Clinical features of anxiety disorders
The ICD10 diagnostic criteria for all types of anxiety disorder stipulate the presence of both emotional and physiological symptoms, either in a specific feared situation or for a specific duration.
Separation anxiety disorder
Separation anxiety disorder is an excessive and/ or developmentally inappropriate anxiety about separation from attachment figures. Excessive worrying about the figure's welfare may also occur. Impairment might include school refusal (possibly exacerbated by specific school anxiety), avoidance of visiting friends' homes or difficulty sleeping alone. The ICD10 criteria include onset before 6 years of age and duration of at least 4 weeks.
Generalised anxiety disorder
Generalised anxiety disorder encompasses multiple and persistent worries (e.g. regarding family, friendships, school or appearance) not restricted to any one situation or object, lasting at least 6 months. Comorbidity (e.g. with depression) is particularly common. In ICD10, diagnostic criteria for children and adolescents are differentiated from those for adults. The former include an additional 'difficult tocontrol worries' criterion, and requires three or more physical symptoms from six, a condensed list to reflect the reduced prominence of autonomic arousal in children.
It is not clear yet what modifications will be made in the revised version, ICD11, although Shear (2012) proposes various changes for the adult criteria, including a requirement that worry must occur frequently and/or excessively, focusing the somatic criteria on restlessness and muscle tension, and permitting the diagnosis even in the presence of other anxiety disorders. Interestingly, these criteria are already present in the ICD10 children's diagnosis. After Marks & Nesse (1994) .
Anxiety disorders in children and adolescents
Social phobia and social anxiety disorder of childhood
Social phobia is accompanied by an excessive fear of embarrassment or scrutiny. Avoidance of particular social situations reinforces the associated anxiety and could eventually impede social skills development and, at the most extreme, result in debilitating social isolation. In DSM5, 'social phobia' is a single category, but in ICD10 it is differentiated from 'social anxiety disorder of childhood' (American Psychiatric Association 2013). Social anxiety disorder of childhood occurs at a developmental stage at which social anxiety reactions are appropriate -diagnostically, it must manifest before 6 years of age -but in an affected child they involve significant severity, persistence or impairment lasting for at least 4 weeks. In contrast, social phobia reflects social anxiety later in life, and includes blushing, shaking, or fear of vomiting, micturition or defecation; no minimum duration of symptoms is given. Emmelkamp (2012) argues that ICD11 should also include a minimum symptom duration for social phobia, following the new inclusion of a minimum 6 months' duration in DSM5. Wittchen et al (1999) distinguish between generalised social phobia (across multiple settings) and non generalised: the former is associated with greater chronicity, impairment and comorbidity. Autism spectrum disorder is a differential (particularly where social isolation is a function of impaired social communication and/or lack of social interest rather than frank anxiety) or commonly comorbid diagnosis.
Specific or simple phobias
Specific or simple phobias are defined by excessive fear of specific objects or situations that provoke an immediate anxiety response on exposure, causing significant distress and/or functional impair ment, for example because of avoidance. Fyer (1998) describes subtypes relating to: animals, specific situations, nature/environment (e.g. water, heights) and blood injury. Not only do they differ in their triggers, they may also vary with respect to symptomatology, age at onset and heritability. Blood injury phobia, for example, has a distinct biphasic physiological response. Some typical fears held by children and adolescents are described in Table 2 . The DSM5 criteria no longer require the individual to recognise that their anxiety is excessive or unreasonable: instead, the onus is on the clinician to determine whether anxiety is disproportionate to the situation.
This particular DSM5 criterion of due proportion also relates to agoraphobia, which encompasses an often overlapping cluster of phobias relating to at least two of crowds, public places, leaving home and travelling alone. Various specific worries may reinforce the anxiety, including fears of collapsing, being left helpless in public and being unable to escape. Persistent avoidance may result in the experience of minimal anxiety, so that the agoraphobia escalates until the individual becomes housebound.
Panic disorder
Panic disorder involves repeated and unexpected attacks of severe anxiety not restricted to any particular situation, accompanied by multiple physical symptoms. It often originates from the occasional panic attack in adolescence, although only a small proportion of young people who have such attacks subsequently develop the disorder. Anticipatory anxiety about future attacks or their perceived implications (e.g. losing control, being judged) is common. In keeping with ICD10, DSM5 has now separated agoraphobia and panic disorder into distinct entities, particularly as many individuals with agoraphobia do not experience panic symptoms.
Assessment
Children and young people with anxiety disorders may not present to services overtly complaining of anxiety. They may also have difficulty articulating their experiences or be confused or embarrassed by them. Nevertheless, making an early diagnosis is important, as many anxiety disorders remain untreated in the community, causing distress and impeding academic and social functioning.
Assessment should differentiate between develop mentally appropriate fears and anxiety disorders. It should also consider potential aetiological factors and developmental influences. Differential and comorbid diagnoses include autism spectrum disorder, oppositional defiant disorder, ADHD, depression and PTSD. Differentiating between diagnoses can be challenging given the overlapping symptoms. For example, fatigue, irritability, and sleep and concentration problems can occur in both generalised anxiety and depression.
Historytaking should aim to exclude medical disorders and drugs that can mimic or provoke anxiety states (Table 4) . If an organic disorder suggests itself, it can be followed up through physical examination and targeted investigations (BMJ Evidence Centre 2016). Liaison with general prac titioners and/or paediatricians may be indicated.
Validated selfreport scales, such as the Multi dimensional Anxiety Scale for Children (MASC; March 1997) and the Screen for Child Anxiety Vallance & Fernandez Related Disorders (SCARED; Birmaher 1997), have shown correlation with anxiety severity and treatment effects. Clinician scales include the Pediatric Anxiety Rating Scale (PARS; Research Unit on Pediatric Psychopharmacology Anxiety Study Group 2003) . Assessment should also focus on the distress and impairment to the individual and their family. This would include suicidality, which is increased in anxiety disorders. Adolescents may also resort to alcohol and other substances as ways of coping.
Aetiology
Despite their symptomatic variation, anxiety disorders may share some common aetiological or pathophysiological characteristics.
Temperament
Research suggests a relationship between pre existing personality traits and later anxiety disorders. One such trait is inhibited temperament, or behavioural inhibition, defined by Kagan and colleagues as a tendency to show apprehension to novel or unfamiliar situations, together with raised reactivity of the sympathetic nervous system (Kagan 1999) . Such behavioural inhibition in early childhood is a risk factor for anxiety, particularly social phobia, later in childhood and adolescence (PerezEdgar 2005) . Similar associations have been reported for shyness and an anxiousresistant attachment style. The 21year longitudinal study by Goodwin et al (2004) showed that anxious/ withdrawn behaviour at 8 years of age increased the risk of anxiety disorders and depression in adolescence and young adulthood.
However, the relationship is complex, it varies according to the study (Degnan 2010) and much of the association may lie at the extremes of temperament (Kagan 2002) . Furthermore, other moderating factors (e.g. peer rejection, exclusion and victimisation) play a significant role as the child develops.
Genetics
Family studies indicate an association between parental anxiety and depression and anxiety disorders in offspring. The association appears to be largely nonspecific (in terms of anxiety subcategory), except for a particular relationship between parental panic disorder and offspring separation anxiety disorder (Biederman 2004) .
Twin studies in adults suggest that generational transmission is primarily accounted for by non shared environmental and genetic factors, with a heritability of about 40% for panic, generalised and agoraphobic anxiety, and specific phobias (Hettema 2001) . Such studies in children show more variation. For example, Bolton et al (2006) reported a heritability of 60% for specific phobias and 73% for separation anxiety disorder, whereas Eley et al (2008) found the figures to be 46% and 14% respectively. Both studies show significant influence of nonshared environmental factors. However, the latter study also shows a significant shared environmental contribution for specific phobia (at 0.27, as for nonshared factors), which suggests that familial factors (such as parental overprotection or control) may be as influential as nonshared factors (e.g. conditioning) for this disorder.
Furthermore, research indicates both common and distinct genetic aetiologies across some types of anxiety and affective disorder. For example, generalised anxiety and major depressive disorders appear to share a common genetic aetiology, but diverge in their nonshared environmental factors. Twin studies in adults indicate a similar genetic substrate underlying panic disorder and generalised anxiety disorder, but a distinct one for specific phobias (Hettema 2005) . Another twin study showed a shared genetic diathesis between adultonset panic attacks and earlier separation anxiety disorder, but not for what was previously Eley et al (2008) , however, showed no significant genetic covariation between specific phobias, separation anxiety and social phobia, implying distinct biological substrates for each. Twin studies therefore indicate that genetic factors endow a broad susceptibility to anxiety in general as opposed to a specific disorder. This again may reflect an evolutionary 'balancing act' between specialisation (to deal potently with specific threats) and generalisation (necessary for protection against several types of danger arising from the evolutionary coexistence of multiple threats). There is probably a stronger relationship between genetic factors and various neuropsychological processes (including behavioural inhibition) or traits (e.g. neuroticism), rather than specific psychiatric disorders.
Finally, adult molecular genetic studies suggest serotonin transporter dysfunction, although paediatric studies are few. Fox et al (2005) explored gene-environment interaction and showed that children with a combination of the short 5HTT allele and low social support had increased risk for behavioural inhibition.
Neuroimaging and neuropsychology
The few neuroimaging studies conducted with children have shown some interesting structural findings. Replicating results in adults, Koolschijn et al (2013) found an association between reduced left hippocampal volume and higher scores for anxiety and depression on the Child Behavior Checklist. Milham et al (2005) found reduced left amygdala grey matter volume associated with anxiety disorders. Intriguingly, a pilot followup study showed recoveries in amygdala grey matter volume after successful 8week intervention with selective serotonin reuptake inhibitors (SSRIs) or psychotherapy.
Various studies have explored relationships between early temperament and neuroanatomy or neurophysiology. Schwartz et al (2003) used functional magnetic resonance imaging (MRI) to show that adults who had had an inhibited (compared with uninhibited) temperament at 2 years old showed greater amygdala signal response to novel faces. Schwartz et al (2010) subsequently used structural MRI to show that adults who had had a lowreactive temperament in infancy showed greater left orbitofrontal cortex thickness, whereas those who had had high reactivity showed greater right ventromedial prefrontal cortex thickness. Functional MRI research in young people with generalised anxiety disorder has shown that variations in state anxiety modulate associations between attention and activation in a 'fear circuit' encompassing the amygdala, ventral prefrontal cortex and the anterior cingulate cortex (McClure 2007) . Pine (2007) has attempted to unify neuroimaging research (e.g. amygdala-prefrontal circuitry abnor malities) with affective and cognitive research (e.g. memory, learning, emotional regulation and fear conditioning) in a single neuropsychological model. This describes various informationprocessing biases in anxiety disorder: for example, the tendency to direct attention towards environmental threats, and appraise such threats as particularly meaningful and dangerous. The development of neural substrates underlying the fear response and anxiety is likely to involve complex geneenvironment interplay, including the influence of early life experiences .
Parent-child interactions and the family environment
Retrospective and observational studies have found that parental over control, rejection and modelling of anxious behaviours are consistently and significantly associated with childhood shyness and paediatric anxiety disorders (Degnan 2010) . Specifically, aspects of parenting behaviour (e.g. oversolicitous, intrusive or controlling parenting), style (e.g. authoritarian, permissive, lowproactive and lowsupportive parenting as perceived by children, or overprotective parenting as reported by parents), psychopathology (e.g. parents diagnosed with panic disorder and/or depression), personality (e.g. maternal neuroticism) and the parent-child relationship (e.g. insecure attachment) have been linked to heightened behavioural inhibition and/or anxiety in children. Parenting factors are therefore likely moderators of the relationship between behavioural inhibition and the development of childhood anxiety. However, the degree to which the child's anxiety has a reverse influence on parenting is unclear. These parenting styles are also implicated in other child psychiatric disorders.
Such parenting may hinder the development of autonomy, resulting in a child who experiences the environment as more threatening and less safe. Lack of parental emotional availability, for example as a result of social adversities such as overcrowding, poverty and marital discord, may impede parents' ability to help contain their children's anxieties; children living in families where there are such chronic stressors are more likely to experience insecurity and to feel anxious and fearful. Also, parents who themselves have increased trait anxiety and sense of threat may exacerbate the perception of threat in these children and obstruct the development of coping skills; modelling may therefore be a significant contributing factor. Parent-child interaction also, of course, occurs in utero, and research shows that maternal stress or anxiety in pregnancy can influence psychopathology in the offspring (Glover 2011) . Bergman et al (2007) showed that prenatal stress predicts observed fearfulness in the offspring. Van den Bergh & Marcoen (2004) used multiple regression analysis to show that maternal state anxiety in the second (but not the third) trimester correlates with anxiety in 8 and 9yearolds. O'Connor et al (2002) showed that antenatal anxiety (but not depression) in late pregnancy is independently associated with behavioural/emotional problems in 4yearolds.
Prenatal stress may also lead to neuroanatomical changes in offspring, such as reduced hippocampal and grey matter volume (Glover 2011) , consistent with neuroimaging data discussed above. From an evolutionary perspective, the effects of prenatal stress on fetal neurodevelopment may allow offspring to readily adapt to the same potentially stressinducing environment as experienced by the mother. Glover (2011) also suggests that outcomes become nonadaptive if the manifesting anxiety is excessively extreme for the respective environment.
Traumatic life events
Traumatic events predispose not only to PTSD, but also to various anxiety disorders, particularly specific phobia and social phobia (McLaughlin 2012). Pine et al 's (2002) longitudinal study found that adverse life events in adolescence were associated with symptoms of generalised anxiety disorder in adulthood, but only in females.
Respiratory dysregulation
Recurrent dyspnoea, particularly in asthma, is a risk factor for paediatric anxiety disorders such as panic and separation anxiety (Goodwin 2003) . Sensitivity to carbon dioxide, a respiratory stimulant, has also been found in children with anxiety disorders, particularly separation anxiety (Pine 2005) .
Interventions
The National Institute for Health and Care Excellence (NICE) guideline on generalised anxiety and panic disorders in adults covers principles that can be extrapolated to children and adolescents (NICE 2011) . For example, early psychoeducation can help families understand the condition and provide reassurance, and selfhelp may encompass written and electronic materials. Interventions with a significant evidence base include cognitivebehavioural therapy (CBT) and SSRI medication. It is important to ascertain the expectations and preferences of the young people and their families and to make treatments developmentally appropriate.
CBT and psychological therapy
As already mentioned, the NICE guideline recom mends CBT for anxiety disorders. It incorporates both cognitive (e.g. reframing, positive selftalk, challenging unhelpful thoughts, and weighing up evidence for and against expected events) and behavioural processes (e.g. systematic de sensi tisation, exposure and response prevention for specific phobias, relaxation training, modelling and rewarding wanted behaviour, and roleplay).
Depending on the anxiety disorder and the child's age, either cognitive or behavioural strategies can be emphasised. Various manuals (e.g. Stallard 2002) provide accessible material for both clinician and patient. Family and school can support the child and help with graded exposure tasks and experiments such as those described by Kendall et al (2005) .
Two relatively recent metaanalyses of psycho logical therapies for anxiety disorders in children and young people (Ishikawa 2007; Reynolds 2012) also included a few trials relating to PTSD and OCD (Table 5 ). Both metaanalyses showed signifi cant effect sizes for CBT, which remained significant but attenuated when analysis was limited to stud ies with an active control methodology (as opposed to waitinglist or treatmentasusual groups). Both reported that involving parents had a positive but, perhaps surprisingly, relatively minor effect.
These two metaanalyses also yielded some divergent data, possibly because of their differing inclusion criteria, number of studies included, date of publication and outcome measures. While the Ishikawa team found little difference in effect size between delivering fewer versus many sessions, the Reynolds team showed that having less than 9 hours of therapy reduced the effect size and less than 4 hours had minimal therapeutic effect. And whereas the Ishikawa team demonstrated little difference in effect size between group and individual CBT, the Reynolds team showed a particularly high effect size for individual CBT. However, delivering CBT to a group may arguably enhance efficiency and provide peer support and reassurance. An open trial has recently shown evidence supporting a novel CBT package (Emotion Detectives Treatment Protocol) delivered to a group of children with various anxiety and depressive disorders (Bilek 2012) .
Computerised CBT packages such as Stressbusters (Abeles 2009 ) have now been developed for childhood anxiety disorders. Their advantages and disadvantages are listed in Box 1 (Richardson 2010) . Two randomised controlled trials (RCTs), each with over 70 participants, showed significant differences between CBT (using the BRAVEONLINE package) and control groups. Furthermore, remission rates in the treatment groups were approximately 75% at 6 months (March 2009 ) and at 12 months (Spence 2006) . Spence et al's study also included a clinicbased CBT arm; overall results showed no significant difference between internet and clinicdelivered CBT.
The evidence base for other forms of psychological therapy is less robust. Family therapy may help where dysfunctional patterns of family interaction influence the child's anxiety symptoms. Parents may also need support for their own difficulties with anxiety and/or separation to prevent them from exacerbating their child's symptoms.
Pharmacotherapy
Although NICE guidelines on paediatric social anxiety recommend that medication not be 'routinely' offered (NICE 2013), a Cochrane review concludes that several RCTs demonstrate SSRIs to be effective and generally welltolerated treatments for paediatric anxiety disorders (Ipser 2009 ). From 14 RCTs of SSRIs and SNRIs (serotoninnoradrenaline reuptake inhibitors) for paediatric anxiety disorders, the combined treatment response was significantly greater with medication (58.1%) than with placebo (31.5%), with NNT of 4. The NICE guidelines for adults advise that medication or CBT be tried if selfhelp or psychoeducational groups are unsuccessful, or if there is signifi cant impairment. However, in children, research has shown added efficacy of combining medication with CBT (Walkup 2008) . In practice, medication tends to be used in combination with psychological therapy where possible, and is perhaps most considered in older children with more severe symptoms, taking into account sideeffect profiles and comorbid conditions. Pharmacotherapy practice has shifted away from tricyclic antidepressants towards SSRIs for childhood anxiety disorders. These have a stronger evidence base and safer sideeffect profiles, including relative safety in over dose. Research has demonstrated the efficacy of fluoxetine and fluvoxamine for paediatric social phobia, generalised anxiety disorder and separation anxiety disorder (Research Unit on Pediatric Psychopharmacology Anxiety Study Group 2001; Birmaher 2003) . Two studies support efficacy and tolerability of sertraline for childhood generalised anxiety disorder (Rynn 2001; Walkup 2008) ; Walkup et al's study also included participants with social phobia and separation anxiety.
In studies of children and adolescents, the therapeutic use of SSRIs has been associated with suicidal ideation and nonfatal suicidal acts (of the order of 4%, v. about 2% in placebo groups), although the benefit of using them might outweigh the risk of emergent suicidal behaviour (Hawton 2012) . This risk appears to relate to other diagnoses as well as depression. For depressive disorder, the Medicines and Healthcare products Regulatory Agency (MHRA; and NICE advise that only fluoxetine has a favourable riskbenefit profile, making it the firstline SSRI for depression. However, a recent reevaluation by NICE of evidence on depression has shown no increase in suicidal ideation in young people treated with antidepressants and psychological therapy (Hopkins 2015) . Although the situation regarding the relationship between suicidality and antidepressants in anxiety disorders is less clear, the Cochrane review of antidepressant use in paediatric anxiety disorders (Ipser 2009 ) indicated an absolute rate of suicidal ideation of approximately 1%, primarily those taking paroxetine or venlafaxine. In the UK, no antidepressants are currently licensed for paediatric anxiety disorders, although sertraline and fluvoxamine are licensed for paediatric OCD.
There is little evidence to support the use of nonantidepressant medication. Studies have failed to show significant efficacy of benzodiazepines, and their sideeffects, for example behavioural disinhibition, are a risk. Such sideeffects can also occur for buspirone, although case reports and open studies have shown some efficacy. There have been few studies of beta blockers. Further information on pharmacotherapy in paediatric anxiety disorder can be found in Sinita & Coghill (2014) .
Prognosis
Studies evaluating longitudinal outcomes indicate that childhood anxiety disorders generally remit. For example, the prospective study by Last et al (1996) on children with a mean age of 12 years found that recovery rates over 3-4 years were 96% for separation anxiety disorder, 86% for social anxiety disorder, 80% for overanxious disorder, and about 70% for specific phobia and panic disorder. The prognosis for anxiety disorders depends on type of disorder, comorbidity, age at onset and severity at baseline. The 2year longitudinal study by Broeren et al (2013) , exploring developmental trajectories for various types of childhood anxiety symptoms, also showed that high levels of initial behavioural inhibition correlated with 2year trajectories of higher anxiety.
A review by Weems (2008) describes some inconsist encies across different research studies. For example, prospective longitudinal studies of childhood anxiety disorders have reported estimates of stability from 4 to 80%. These studies may show wide variability for many reasons (e.g. disorder type, age at onset, the informant, the sample, and the method and duration of assessment). Age at onset may be a significant factor, since there are specific age differences in the predominant expression of the symptoms of childhood anxiety: epidemiological data on the age at onset of anxiety disorders are generally consistent with the normative trajectories of fear development (Tables 2 and 3) .
Concerning the prediction of adultonset anxiety disorders, studies often point to little specificity. The community epidemiological study by Bittner et al (2007) showed that various anxiety disorders in childhood predicted anxiety and other psychiatric disorders in adolescence; the only exception was that generalised anxiety disorder specifically predicted only conduct disorder. In contrast, the longitudinal study by Pine et al (1998) showed that adolescent social phobia predicted primarily social phobia in adulthood, whereas simple phobias predicted primarily simple phobias. They also found broad associations between generalised anxiety, panic and major depressive disorders, with a particularly strong association between adolescent depression and adult generalised anxiety disorder. The 7year longitudinal study by Aschenbrand et al (2003) explored whether childhood separation anxiety specifically constitutes a precursor for later panic disorder and agoraphobia, but found no evidence of this. Overall, adolescent anxiety or depression predicts an approximate two to threefold increase in risk for adult anxiety disorders (and for suicide attempts, psychiatric admissions, and alcohol and substance misuse).
Weems (2008) argues for heterotypical continuity in anxiety disorder: although an individual's anxiety disorder may remit and return, often as a different disorder type, underneath lies a core maladaptive anxiety emotion that exhibits a larger degree of continuity. Various aetiological factors (e.g. genetic, temperamental, neuropsychological, interpersonal and environmental) may influence the emergence and course of anxiety disorders; normative developmental changes may also affect their trajectory and expression into specific disorders.
Conclusions
Paediatric anxiety disorders are relatively common and often disabling. They increase the risk of psychopathology in adult life, especially anxiety and depressive disorders. This chapter has necessarily presented a succinct review of a vast topic. The changing classifications require clinicians to be familiar with diagnostic criteria in order to detect these disorders, which are so often comorbid with other childhood psychiatric presentations. Research evidence is accumulating about the aetiology of these conditions, the contribution of genetics and environmental events, and the influence of parent and family interactions. Insights into the neuroimaging and neuropsychological findings are intriguing. Increasing our understanding of evidencebased interventions, including the role of psychopharmacology, is essential so that targeted interventions can be used to inform and support families and improve children's symptoms.
